NasdaqCM - Delayed Quote USD

Bellevue Life Sciences Acquisition Corp. (BLAC)

Compare
11.40
+0.06
+(0.53%)
At close: January 3 at 4:00:00 PM EST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Kuk Hyoun Hwang CEO & Executive Chairman -- -- 1976
Mr. David Jin Yoo Chief Financial Officer -- -- 1974

Bellevue Life Sciences Acquisition Corp.

10900 NE 4th Street
Suite 2300
Bellevue, WA 98004
United States
425 635 7700 https://www.bellevuespac.com
Industry: 
Shell Companies

Description

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Corporate Governance

Bellevue Life Sciences Acquisition Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

January 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 27, 2024 at 12:00 AM UTC

S-4/A: Offering Registrations

December 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 8, 2024 at 12:00 AM UTC

S-4/A: Offering Registrations

October 28, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

October 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 10, 2024 at 12:00 AM UTC

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Related Tickers